Utah Medical Products
UTMD
UTMD
89 hedge funds and large institutions have $213M invested in Utah Medical Products in 2023 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 34 increasing their positions, 30 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
2% less funds holding
Funds holding: 91 → 89 (-2)
22% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 9
Holders
89
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.42M | |
| 2 | +$1.39M | |
| 3 | +$590K | |
| 4 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$484K |
| 5 |
JPMorgan Chase & Co
New York
|
+$452K |
Top Sellers
| 1 | -$5.07M | |
| 2 | -$1.42M | |
| 3 | -$1.1M | |
| 4 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
-$558K |
| 5 |
Goldman Sachs
New York
|
-$543K |